These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22128776)

  • 1. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.
    Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA
    Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
    Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C
    Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
    Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):246-52. PubMed ID: 19965776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
    Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA
    Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.
    Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ
    J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
    Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.
    Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
    Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits.
    Nicholls SJ; Dusting GJ; Cutri B; Bao S; Drummond GR; Rye KA; Barter PJ
    Circulation; 2005 Mar; 111(12):1543-50. PubMed ID: 15781735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory functions of apolipoprotein A-I and high-density lipoprotein are preserved in trimeric apolipoprotein A-I.
    Murphy AJ; Hoang A; Aprico A; Sviridov D; Chin-Dusting J
    J Pharmacol Exp Ther; 2013 Jan; 344(1):41-9. PubMed ID: 23033374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.
    Calabresi L; Franceschini G; Sirtori CR; De Palma A; Saresella M; Ferrante P; Taramelli D
    Biochem Biophys Res Commun; 1997 Sep; 238(1):61-5. PubMed ID: 9299452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo.
    Puranik R; Bao S; Nobecourt E; Nicholls SJ; Dusting GJ; Barter PJ; Celermajer DS; Rye KA
    Atherosclerosis; 2008 Jan; 196(1):240-247. PubMed ID: 17586510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
    Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA
    Circ Res; 2013 Jan; 112(2):278-88. PubMed ID: 23123430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.
    Patel S; Puranik R; Nakhla S; Lundman P; Stocker R; Wang XS; Lambert G; Rye KA; Barter PJ; Nicholls SJ; Celermajer DS
    Atherosclerosis; 2009 Jun; 204(2):424-8. PubMed ID: 19111829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation.
    Muñoz-Vega M; Massó F; Páez A; Vargas-Alarcón G; Coral-Vázquez R; Mas-Oliva J; Carreón-Torres E; Pérez-Méndez Ó
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
    J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
    Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
    Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
    Cho KH; Kim JR
    Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Vascular Inflammation by Apolipoprotein A-IV.
    Shearston K; Tan JTM; Cochran BJ; Rye KA
    Front Cardiovasc Med; 2022; 9():901408. PubMed ID: 35845068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.